SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,672 | -13.2% | 641 | -5.3% | 0.00% | – |
Q2 2023 | $20,350 | -18.5% | 677 | -1.7% | 0.00% | – |
Q1 2023 | $24,963 | -0.3% | 689 | -1.9% | 0.00% | – |
Q4 2022 | $25,041 | -10.6% | 702 | -13.8% | 0.00% | – |
Q3 2022 | $28,000 | +16.7% | 814 | 0.0% | 0.00% | – |
Q2 2022 | $24,000 | +200.0% | 814 | +216.7% | 0.00% | – |
Q1 2022 | $8,000 | +14.3% | 257 | 0.0% | 0.00% | – |
Q4 2021 | $7,000 | +40.0% | 257 | +49.4% | 0.00% | – |
Q3 2021 | $5,000 | 0.0% | 172 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | 0.0% | 172 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | +25.0% | 172 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | 0.0% | 172 | 0.0% | 0.00% | – |
Q3 2020 | $4,000 | 0.0% | 172 | 0.0% | 0.00% | – |
Q2 2020 | $4,000 | -63.6% | 172 | -72.8% | 0.00% | – |
Q1 2020 | $11,000 | +22.2% | 633 | +63.1% | 0.00% | – |
Q4 2019 | $9,000 | -30.8% | 388 | -17.6% | 0.00% | – |
Q3 2019 | $13,000 | -18.8% | 471 | 0.0% | 0.00% | – |
Q2 2019 | $16,000 | -89.8% | 471 | -89.5% | 0.00% | -100.0% |
Q1 2019 | $157,000 | +946.7% | 4,485 | +881.4% | 0.00% | – |
Q4 2018 | $15,000 | 0.0% | 457 | +54.4% | 0.00% | – |
Q3 2018 | $15,000 | -76.9% | 296 | -72.8% | 0.00% | -100.0% |
Q2 2018 | $65,000 | +30.0% | 1,089 | -1.2% | 0.00% | 0.0% |
Q1 2018 | $50,000 | +525.0% | 1,102 | +468.0% | 0.00% | – |
Q4 2017 | $8,000 | -11.1% | 194 | -10.6% | 0.00% | – |
Q3 2017 | $9,000 | 0.0% | 217 | 0.0% | 0.00% | – |
Q2 2017 | $9,000 | – | 217 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |